Title: Executive/Senior Medical Director
Reports to: Vice President, Clinical Development
Education: Board certification in Internal Medicine, and preferably additional Board Certification in Pulmonary Medicine or Oncology
This role represents a unique opportunity for a physician experienced in clinical trial design and conduct to expand his or her experience across all medical aspects of drug development, including clinical development, medical affairs, and pharmacovigilance. This physician will serve as the Promedior Medical Monitor for a Phase 2 Study of PRM-151 in either Idiopathic Pulmonary Fibrosis (IPF) or myelofibrosis (MF), working closely with the VP, Clinical Development, Senior Director of Clinical Operations, and Contract Research Organization (CRO), to ensure optimal enrollment and conduct of the clinical trial, will participate in or lead all advisory boards and interactions with regulatory authorities regarding the study and future development, and will have primary medical responsibility for data analysis, clinical study report and publications for the trial. He or she will be the primary Promedior liaison with clinical trial investigators and key opinion leaders. This physician will also be responsible for pharmacovigilance activities for PRM-151 for the MF or IPF Phase 2 trial, including attending the Promedior Executive Safety Committee.
- Experience in clinical trial design and conduct in either pulmonary diseases, preferably Idiopathic Pulmonary Fibrosis, or in oncology
- Experience in data analysis and manuscript writing
- Outstanding interpersonal and presentation skills
- 3-8 years industry experience